產(chǎn)品搜索
相關(guān)文章
- PD-1阻斷療法激活的T細(xì)胞還需依賴CD28共刺激
- 一個(gè)好的ATCC細(xì)胞株有多方面要求
- 【連載-企業(yè)參考品】 前列腺癌的診斷參考品的選擇
- 有關(guān)腫瘤細(xì)胞的基因突變研究講解
- ATCC細(xì)胞的貼壁過(guò)程有何特點(diǎn)呢?
- IL2細(xì)胞篩選模型
- 【靶點(diǎn)模型+診斷質(zhì)控】BCR-ABL1的藥物開(kāi)發(fā)和診斷
- *針對(duì)肝癌的PD-1抗體獲FDA批準(zhǔn),國(guó)產(chǎn)PD-1抗體進(jìn)入三期
- Cell Metab:雙信號(hào)通路失調(diào)協(xié)同促進(jìn)肺癌形成
- 【連載-企業(yè)參考品】胃癌的診斷參考品的選擇
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73255CSF3R S783fs/BaF3
- 詳細(xì)內(nèi)容
CBP73255 | |
| I. Introduction | |
Cell Line Name: | CSF3R S783fs/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
| II.Background | |
CSF3R S783fs results in a change in the amino acid sequence of the Csf3r protein beginning at aa 783 of 836, likely resulting in premature truncation of the functional protein (UniProt.org). S783fs does not result in increased Stat3 activation (PMID: 23656643, PMID: 24403076), however, results in increased Src activation and transformation in cell culture (PMID: 23656643), and therefore, is predicted to result in a gain of Csf3r protein function. | |
| III. Representative Data | |
1.WB of CSF3R S783fs/BaF3
| |
2. Anti-proliferation assay | |
| |
Figure 2. Anti-proliferation assay of three reference compounds on the CSF3R S783fs/BaF3. | |






會(huì)員_a.png)